![Alfonso Valle on X: "#Cardio-Oncology by @TeresaLpezFdez1 🧑💻272 new recommendations‼️ 🥇 ACE- or ARB and beta-blockers recomended for HF should be considered for primary preventjon in high- and very high-risk 👥 receiving Alfonso Valle on X: "#Cardio-Oncology by @TeresaLpezFdez1 🧑💻272 new recommendations‼️ 🥇 ACE- or ARB and beta-blockers recomended for HF should be considered for primary preventjon in high- and very high-risk 👥 receiving](https://pbs.twimg.com/media/FbEbBg0WAAAEMsC.jpg:large)
Alfonso Valle on X: "#Cardio-Oncology by @TeresaLpezFdez1 🧑💻272 new recommendations‼️ 🥇 ACE- or ARB and beta-blockers recomended for HF should be considered for primary preventjon in high- and very high-risk 👥 receiving
![Frontiers | Inequity in care delivery in cardio-oncology: dissecting disparities in underrepresented populations Frontiers | Inequity in care delivery in cardio-oncology: dissecting disparities in underrepresented populations](https://www.frontiersin.org/files/Articles/1124447/fonc-13-1124447-HTML-r1/image_m/fonc-13-1124447-g001.jpg)
Frontiers | Inequity in care delivery in cardio-oncology: dissecting disparities in underrepresented populations
![Navigating Cardio-Oncology with Tochukwu Okwuosa, DO: Expert Insights, the 2022 ESC Guidelines, and More - Advanced Practice Providers Oncology Summit - APPOS Navigating Cardio-Oncology with Tochukwu Okwuosa, DO: Expert Insights, the 2022 ESC Guidelines, and More - Advanced Practice Providers Oncology Summit - APPOS](https://apponcologysummit.org/wp-content/uploads/2023/11/Cardio-oncology.png)
Navigating Cardio-Oncology with Tochukwu Okwuosa, DO: Expert Insights, the 2022 ESC Guidelines, and More - Advanced Practice Providers Oncology Summit - APPOS
Guías Europeas de Cardio-Oncología, 2022: ¿qué nos dicen sobre los cuidados cardiovasculares cuando se
![Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy–Related Cardiac Dysfunction | JACC: CardioOncology Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy–Related Cardiac Dysfunction | JACC: CardioOncology](https://www.jacc.org/cms/asset/383d4794-594a-4154-a655-88b7241bfd41/ga1.jpg)
Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy–Related Cardiac Dysfunction | JACC: CardioOncology
![2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - - 2022 - European Journal of Heart Failure - Wiley Online Library 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - - 2022 - European Journal of Heart Failure - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/93d4d677-e5c3-4b03-86d8-f976d3e33940/ejhf2333-fig-0018-m.jpg)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - - 2022 - European Journal of Heart Failure - Wiley Online Library
![ESC Cardio-oncology quality indicators for the management of patients... | Download Scientific Diagram ESC Cardio-oncology quality indicators for the management of patients... | Download Scientific Diagram](https://www.researchgate.net/publication/364972245/figure/tbl1/AS:11431281094362763@1667459970349/ESC-Cardio-oncology-quality-indicators-for-the-management-of-patients-with-cancer-or.png)
ESC Cardio-oncology quality indicators for the management of patients... | Download Scientific Diagram
![Webinar - 2022 ESC Guidelines on Cardio-Oncology: how to implement cancer treatment monitoring in daily practice Webinar - 2022 ESC Guidelines on Cardio-Oncology: how to implement cancer treatment monitoring in daily practice](https://ptkardio.pl/resources/data/aktualnosci/707/esc_cardiooncology.png)